Left Menu
Development News Edition

Gilead's remdesivir gets U.S. FDA approval for hospitalized COVID-19 patients

Also on Thursday, the FDA issued a new emergency use authorization for remdesivir to treat hospitalized pediatric patients under age 12 who weigh enough to receive an intravenous drug. Gilead said it is still working to understand the full potential of Veklury, in different settings and as part of combination therapy approaches.

Reuters | Washington DC | Updated: 23-10-2020 03:16 IST | Created: 23-10-2020 02:46 IST
Gilead's remdesivir gets U.S. FDA approval for hospitalized COVID-19 patients
Representative image Image Credit: ANI

The U.S. Food and Drug Administration on Thursday approved Gilead Sciences Inc's antiviral drug remdesivir for treating patients hospitalized with COVID-19, making it the first and only drug approved for the disease in the United States. Remdesivir, given intravenously, was one of the drugs used to treat U.S. President Donald Trump during his bout with COVID-19.

It has been available under an FDA emergency use authorization since May, after a study led by the National Institutes of Health showed it reduced hospital stays by five days. But the World Health Organization (WHO) last week said its global trial of COVID-19 therapies found that remdesivir did not have a substantial effect on patients' length of hospital stay or chances of survival. That study has not been reviewed by outside experts. Gilead has questioned the potential for bias in the WHO study, which was not "blinded," meaning that participants and their doctors were aware of which treatments were being used.

Remdesivir, which will be sold under the brand name Veklury, costs $3,120 for a five-day treatment course, or $2,340 for government purchasers such as the Department of Veterans Affairs. Shares of Gilead rose 4.3% in after hours trading to $63.30. Gilead said it is currently meeting real-time demand for the drug in the United States and anticipates meeting global demand by the end of October.

The company said its drug has regulatory approvals or temporary authorizations in about 50 additional countries. Also on Thursday, the FDA issued a new emergency use authorization for remdesivir to treat hospitalized pediatric patients under age 12 who weigh enough to receive an intravenous drug.

Gilead said it is still working to understand the full potential of Veklury, in different settings and as part of combination therapy approaches.


TRENDING

OPINION / BLOG / INTERVIEW

Turbulence surrounding tobacco control in Ghana

... ...

Smart healthcare: IoT redefining the way healthcare is delivered

As the world is embracing the new wave of digitalization triggered by the pandemic and the arrival of 5G, the adoption of IoT devices will further boom. With adoption set to soar, IoT security issues and other challenges cant be ignored any...

Refugee compassion and response: Ideas to mitigate disasters now and in their future

Their homeland becomes a forbidden territory for them and more likely than not, their journey to foreign soil is no less traumatizing, not to say deadly. It is crucial to help refugees live a life of dignity and purpose....

Inadequate water infrastructure causes a tidal wave of coronavirus in rural Alaska

... ...

Videos

Latest News

Cricket-Windies to assess Bangladesh bio-security arrangements before tour

Cricket West Indies CWI confirmed on Tuesday the team will be the first to tour Bangladesh since the COVID-19 pandemic struck but said they are sending officials this week to assess bio-security arrangements before the side arrive in Januar...

She one of Asia's Top 30 Under 30 and one of Top 30 Women Transforming India. Meet UTS alum Madhavi Shankar.

SYDNEY, Nov. 25, 2020 PRNewswire -- University of Technology Sydney is hosting its International Virtual Open Day, with respected alumni as featured speakers, including Madhavi Shankar. Hear Madhavis career advice at UTS International Virtu...

Senior leader of India's Congress party dies of coronavirus complications

A senior leader of Indias Congress party died of coronavirus related complications on Wednesday, his family said, a second veteran from the opposition group to fall victim to the virus in recent days, as total cases in the country touched t...

Migratory birds start arriving at Hirakud Dam Reservoir

With the winter setting in, migratory birds have started arriving at the Hirakud Dam Reservoir in Odishas Sambalpur district from across continents. Winged guests like Gull and Black Cormorant have been spotted by the forest officials at th...

Give Feedback